TREATMENT REGIMEN FOR AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES
案件概要
出願人
Merck Patent GmbH
発明者
Yann Hyvert
IPC分類
CPC分類
The present disclosure relates to a novel treatment regimen for the treatment of autoimmune diseases and other inflammatory diseases with BTK (Bruton's tyrosine kinase) inhibitors. In particular, the present disclosure relates to a treatment that combines BTK inhibitor treatment with vaccination to avoid, reduce the risk of contracting or ameliorate an infection. Moreover, the present disclosure relates to vaccination in the presence of a BTK inhibitor.
原文（中国語）
The present disclosure relates to a novel treatment regimen for the treatment of autoimmune diseases and other inflammatory diseases with BTK (Bruton's tyrosine kinase) inhibitors. In particular, the present disclosure relates to a treatment that combines BTK inhibitor treatment with vaccination to avoid, reduce the risk of contracting or ameliorate an infection. Moreover, the present disclosure relates to vaccination in the presence of a BTK inhibitor.
外部リソース